Evaluating the Outcome of Cardio Selective beta1- Blockers Use in Patients With Copd
NCT04845061
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Copd
Interventions
DRUG:
Nebivolol Tablets
Sponsor
Ain Shams University